- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Sun Pharmaceutical Industries Ltd
+ Add to WatchlistSUNP:IN
982.65 INR 23.35 2.32%As of 02:09:05 ET on 05/24/2013.
Snapshot for Sun Pharmaceutical Industries Ltd (SUNP)
| Open: | 988.25 | Day's Range: | 966.00 - 997.80 | Volume: | 640,903 |
|---|---|---|---|---|---|
| Previous Close: | 1,006.00 | 52wk Range: | 553.00 - 1,016.70 | 1-Yr Rtn: | +73.77% |
Key Statistics for SUNP
| Current P/E Ratio (ttm) | 40.2492 |
|---|---|
| Estimated P/E(03/2013) | 31.9426 |
| Relative P/E vs. SENSEX | 2.3776 |
| Earnings Per Share (INR) (ttm) | 24.9943 |
| Est. EPS (INR) (03/2013) | 31.4940 |
| Est. PEG Ratio | 2.2369 |
| Market Cap (M INR) | 1,040,186.13 |
| Shares Outstanding (M) | 1,033.98 |
| 30 Day Average Volume | 1,025,331 |
| Price/Book (mrq) | 8.3620 |
| Price/Sale (ttm) | 12.6860 |
| Dividend Indicated Gross Yield | 0.42% |
| Cash Dividend (INR) | 4.2500 |
| Last Dividend | 08/14/2012 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SUNP
No data available
Company Profile & Key Executives for SUNP
Sun Pharmaceutical Industries Limited manufactures and markets pharmaceuticals for domestic and international distribution. The Company's pharmaceutical portfolio includes drugs in the areas of diabetes, cardiology, neurology, psychiatry and gastroenterology.
| Israel MakovChairman | Dilip Shantilal ShanghviManaging Director |
| Sudhir Vrundavandas ValiaExecutive Director | Sailesh T DesaiExecutive Director |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SUNP News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page